CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development	$ 5,039,228	$ 6,341,171	$ 15,632,150	$ 16,402,129
General and administrative	3,453,648	3,869,481	10,933,411	11,531,824
Total operating expenses	8,492,876	10,210,652	26,565,561	27,933,953
Loss from operations	(8,492,876)	(10,210,652)	(26,565,561)	(27,933,953)
Other income (expense):
Interest income	251,855	5,038	439,590	16,614
Foreign exchange loss	(435,128)	(376,637)	(893,803)	(576,619)
Total other income (expense)	(183,273)	(371,599)	(454,213)	(560,005)
Net loss	$ (8,676,149)	$ (10,582,251)	$ (27,019,774)	$ (28,493,958)
Net loss per share basic	$ (0.20)	$ (0.26)	$ (0.65)	$ (0.73)
Net loss per share diluted	$ (0.20)	$ (0.26)	$ (0.65)	$ (0.73)
Basic weighted average shares outstanding	43,746,878	40,092,128	41,831,998	38,933,209
Diluted weighted average shares outstanding	43,746,878	40,092,128	41,831,998	38,933,209